Quantcast

Latest Pneumococcal conjugate vaccine Stories

2010-12-02 00:41:46

A new study suggests that preterm infants may not be fully protected against invasitve pneumococcal disease under the current United Kingdom immunization schedule. The findings are reported in the November issue of the journal Clinical and Vaccine Immunology. The study, conducted by researchers from Newcastle University, began with a survey of UK neonatal intensive care units. The survey found that preterm infants at increased risk of invasive pneumococcal disease were not being adequately...

2010-11-12 12:32:53

Urgent action needed in the 15 countries responsible for three-quarters of child pneumonia deaths A Pneumonia Report Card released today by the International Vaccine Access Center (IVAC) on behalf of the Global Coalition against Child Pneumonia reveals where urgent efforts are needed to reach target levels of coverage for the life-saving interventions that can prevent, protect against and treat pneumonia in children. Pneumonia is the world's leading infectious killer of young children, taking...

2010-10-06 17:13:51

Only a limited number of Streptococcus pneumoniae serotypes cause most invasive pneumococcal disease worldwide Contrary to current thinking, the group of serotypes of Streptococcus pneumoniae responsible for most invasive pneumococcal disease worldwide is conserved across regions. Streptococcus pneumoniae is the leading bacterial cause of pneumonia, sepsis, and meningitis in children, which together comprise more than 25% of the 10 million deaths estimated to have occurred in 2000 in children...

2010-09-08 13:50:41

Infants who received heptavalent pneumococcal conjugate vaccination (PCV-7) at 2, 4, and 11 months were more likely than unvaccinated controls to have nasopharyngeal (in the nasal passages and upper part of the throat behind the nose) acquisition of pneumococcal serotype 19A, a leading cause of respiratory pneumococcal disease, according to a study in the September 8 issue of JAMA. "A rapid increase in the presence of pneumococcal serotype 19A strains that are often multiresistant to...

2aba617f0d232e38f865fb6820ed7e951
2010-08-29 08:41:15

The number of children admitted to English hospitals with bacterial pneumonia decreased by a fifth in the 2 years following the introduction of a vaccine to combat the disease The number of children admitted to English hospitals with bacterial pneumonia decreased by a fifth in the two years following the introduction of a vaccine to combat the disease, according to a new study published August 27 in the journal Thorax. Bacterial pneumonia is a serious illness caused by Streptococcus...

2010-08-26 07:00:00

SWIFTWATER, Pa., Aug. 26 /PRNewswire/ -- Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced today that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for use of Menactra® (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) for active immunization of infants and toddlers for the prevention of invasive...

2010-08-23 11:01:00

NEW YORK, Aug. 23 /PRNewswire-FirstCall/ -- The World Health Organization (WHO) has granted prequalification to Prevenar 13* (Pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed])for active immunization of infants and children from 6 weeks through five years of age against invasive disease, pneumonia and otitis media caused by the 13 pneumococcal serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F) contained in the vaccine. WHO prequalification allows for the...

2010-08-16 05:30:00

BEIJING, Aug. 16 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading China-based vaccine manufacturer, announced today its unaudited financial results for the three-month and six-month periods ended June 30, 2010. Financial Highlights -- Second quarter sales increased 131% to $10.3 million on a sequential quarter basis and decreased by 49% year-over-year -- Sales for the six-month period declined 45% to $14.7 million, compared to same period last...

2010-07-22 13:17:19

The GAVI Alliance and Johns Hopkins Bloomberg School of Public Health celebrate new vaccine era; applaud Baltimore's efforts to immunize every child; call for resources to do the same worldwide A Johns Hopkins University scientist, whose team of researchers recently identified pneumonia, diarrhea, and malaria as the primary causes of death of 6 million of the world's poorest children, today called on leaders in donor and developing nations to take action to address the terrible death toll....

2010-07-18 23:01:00

PHILADELPHIA, July 19 /PRNewswire-USNewswire/ -- A pneumococcal conjugate vaccine introduced in the U.S. 10 years ago appears to reduce pneumonia and serious associated complications, such as blood infections, in the vaccine's target range, children less than a year old, according to new research. However, pneumonia and associated complications, including a lung infection called empyema, increased in older children, the study found. The results also show a narrowing of racial...


Word of the Day
monteith
  • A large punch-bowl of the eighteenth century, usually of silver and with a movable rim, and decorated with flutings and a scalloped edge. It was also used for cooling and carrying wine-glasses.
  • A kind of cotton handkerchief having white spots on a colored ground, the spots being produced by a chemical which discharges the color.
This word is possibly named after Monteith (Monteigh), 'an eccentric 17th-century Scotsman who wore a cloak scalloped at the hem.'
Related